205 related articles for article (PubMed ID: 1582589)
61. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
[TBL] [Abstract][Full Text] [Related]
62. Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.
Mazzarella G; Stefanile R; Camarca A; Giliberti P; Cosentini E; Marano C; Iaquinto G; Giardullo N; Auricchio S; Sette A; Troncone R; Gianfrani C
Gastroenterology; 2008 Apr; 134(4):1017-27. PubMed ID: 18395083
[TBL] [Abstract][Full Text] [Related]
63. Wheat peptide challenge in coeliac disease.
Sturgess R; Day P; Ellis HJ; Lundin KE; Gjertsen HA; Kontakou M; Ciclitira PJ
Lancet; 1994 Mar; 343(8900):758-61. PubMed ID: 7907731
[TBL] [Abstract][Full Text] [Related]
64. An analysis of cereals that react with serum antibodies in patients with coeliac disease.
Troncone R; Auricchio S; De Vincenzi M; Donatiello A; Farris E; Silano V
J Pediatr Gastroenterol Nutr; 1987; 6(3):346-50. PubMed ID: 3430243
[TBL] [Abstract][Full Text] [Related]
65. Studies of intestinal lymphoid tissue. IX. Dose-dependent, gluten-induced lymphoid infiltration of coeliac jejunal epithelium.
Leigh RJ; Marsh MN; Crowe P; Kelly C; Garner V; Gordon D
Scand J Gastroenterol; 1985 Aug; 20(6):715-9. PubMed ID: 4035290
[TBL] [Abstract][Full Text] [Related]
66. [Interactions between enterocytes and lymphocytes in the pathogenesis of celiac disease].
Mothes T; Wilsdorf A; Müller F
Z Gesamte Inn Med; 1991 Jul; 46(9):306-9. PubMed ID: 1681626
[TBL] [Abstract][Full Text] [Related]
67. Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4.
Troncone R; Gianfrani C; Mazzarella G; Greco L; Guardiola J; Auricchio S; De Berardinis P
Dig Dis Sci; 1998 Jan; 43(1):156-61. PubMed ID: 9508518
[TBL] [Abstract][Full Text] [Related]
68. MICA response to gliadin in intestinal mucosa from celiac patients.
Martín-Pagola A; Pérez-Nanclares G; Ortiz L; Vitoria JC; Hualde I; Zaballa R; Preciado E; Castaño L; Bilbao JR
Immunogenetics; 2004 Nov; 56(8):549-54. PubMed ID: 15490153
[TBL] [Abstract][Full Text] [Related]
69. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
70. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue.
De Angelis M; Rizzello CG; Fasano A; Clemente MG; De Simone C; Silano M; De Vincenzi M; Losito I; Gobbetti M
Biochim Biophys Acta; 2006 Jan; 1762(1):80-93. PubMed ID: 16311022
[TBL] [Abstract][Full Text] [Related]
71. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease.
Fina D; Sarra M; Caruso R; Del Vecchio Blanco G; Pallone F; MacDonald TT; Monteleone G
Gut; 2008 Jul; 57(7):887-92. PubMed ID: 17965065
[TBL] [Abstract][Full Text] [Related]
72. In vitro model of the pathogenesis of celiac disease.
Oberhuber G; Schwarzenhofer M; Vogelsang H
Dig Dis; 1998; 16(6):341-4. PubMed ID: 10207219
[TBL] [Abstract][Full Text] [Related]
73. Breakdown of gliadin peptides by intestinal brush borders from coeliac patients.
Bruce G; Woodley JF; Swan CH
Gut; 1984 Sep; 25(9):919-24. PubMed ID: 6381246
[TBL] [Abstract][Full Text] [Related]
74. Interleukin 15 mediates epithelial changes in celiac disease.
Maiuri L; Ciacci C; Auricchio S; Brown V; Quaratino S; Londei M
Gastroenterology; 2000 Oct; 119(4):996-1006. PubMed ID: 11040186
[TBL] [Abstract][Full Text] [Related]
75. Clinical testing of gliadin fractions in coeliac patients.
Ciclitira PJ; Evans DJ; Fagg NL; Lennox ES; Dowling RH
Clin Sci (Lond); 1984 Mar; 66(3):357-64. PubMed ID: 6692666
[TBL] [Abstract][Full Text] [Related]
76. Immunohistochemical analysis of mucosal gamma-interferon production in coeliac disease.
al-Dawoud A; Nakshabendi I; Foulis A; Mowat AM
Gut; 1992 Nov; 33(11):1482-6. PubMed ID: 1452072
[TBL] [Abstract][Full Text] [Related]
77. Gliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals.
Friis S; Dabelsteen E; Sjöström H; Norén O; Jarnum S
Gut; 1992 Nov; 33(11):1487-92. PubMed ID: 1452073
[TBL] [Abstract][Full Text] [Related]
78. Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.
Ruuskanen A; Luostarinen L; Collin P; Krekelä I; Patrikainen H; Tillonen J; Laurila K; Haimila K; Partanen J; Mäki M; Valve R; Kaukinen K
Dig Liver Dis; 2011 Oct; 43(10):772-8. PubMed ID: 21641886
[TBL] [Abstract][Full Text] [Related]
79. Jejunal plasma cells and in vitro immunoglobulin production in adult coeliac disease.
Wood GM; Howdle PD; Trejdosiewicz LK; Losowsky MS
Clin Exp Immunol; 1987 Jul; 69(1):123-32. PubMed ID: 3652527
[TBL] [Abstract][Full Text] [Related]
80. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa.
Paparo F; Petrone E; Tosco A; Maglio M; Borrelli M; Salvati VM; Miele E; Greco L; Auricchio S; Troncone R
Am J Gastroenterol; 2005 Oct; 100(10):2294-8. PubMed ID: 16181383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
